Eureka Therapeutics: Funding, Investors & Team (Oct 2026)
Eureka Therapeutics is a biotech company based in the San Francisco Bay Area that specializes in developing revolutionary immunotherapies for cancer treatment. Through our advanced technology in antibody drug discovery and engineering, we are able to create safe and effective treatments that target previously inaccessible cancer antigens. Our portfolio includes a range of innovative drugs, with the most promising ones currently in the pre-clinical stage. We are recognized as pioneers in the field of antibody immunotherapies, utilizing a groundbreaking platform to create fully-human antibodies specifically designed to combat intracellular cancer antigens. Our partnership with Memorial Sloan-Kettering Cancer Center led to the successful demonstration of the effectiveness of a human IgG1 antibody against an intracellular cancer antigen. Our most advanced program is currently in the preclinical stage and is being developed in collaboration with Novartis.
Eureka Therapeutics has raised $10.6M across 1 funding round on record, the most recent an undisclosed round of $10.6M announced in Jun 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Eureka Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2023.
Eureka Therapeutics Funding Rounds
Eureka Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Eureka Therapeutics Funding Compared to Other Biotechnology Startups
Eureka Therapeutics' latest round of $10.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Eureka Therapeutics in Biotechnology and Emeryville
Companies Similar to Eureka Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Eureka Therapeutics Funding FAQs
What does Eureka Therapeutics do?
Eureka Therapeutics is a biotech company based in the San Francisco Bay Area that specializes in developing revolutionary immunotherapies for cancer treatment. Through our advanced technology in antibody drug discovery and engineering, we are able to create safe and effective treatments that target previously inaccessible cancer antigens. Our portfolio includes a range of innovative drugs, with the most promising ones currently in the pre-clinical stage. We are recognized as pioneers in the field of antibody immunotherapies, utilizing a groundbreaking platform to create fully-human antibodies specifically designed to combat intracellular cancer antigens. Our partnership with Memorial Sloan-Kettering Cancer Center led to the successful demonstration of the effectiveness of a human IgG1 antibody against an intracellular cancer antigen. Our most advanced program is currently in the preclinical stage and is being developed in collaboration with Novartis.
How much funding has Eureka Therapeutics raised?
Eureka Therapeutics has raised $10.6M across 1 round on record. The most recent is an undisclosed round of $10.6M announced in Jun 2023.
When did Eureka Therapeutics last raise funding?
Eureka Therapeutics' most recent funding round on record is an undisclosed round of $10.6M, announced in Jun 2023.
Who founded Eureka Therapeutics?
FundedIQ lists Cheng Liu (Founder) at Eureka Therapeutics.
Where is Eureka Therapeutics headquartered?
Eureka Therapeutics is based in Emeryville, California, United States.
How many employees does Eureka Therapeutics have?
Eureka Therapeutics is in the 11-50 employee band.
How does Eureka Therapeutics' funding compare to other Biotechnology startups?
Eureka Therapeutics' latest round of $10.6M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Eureka Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Eureka Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.